spacer
The Healthcare Sales & Marketing Network celebrates 24 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Hematide 

 HSMN NewsFeed - 4 Feb 2011
Affymax Announces Appointment of Herb Cross as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2010
Affymax Names Herb Cross as Chief Accounting Officer and Vice President of Finance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2010
Affymax Names John A. Orwin President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2008
Affymax(R) Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 May 2008
Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2007
Affymax(R) Announces Retirement Plans of Robert B. Naso, Ph.D. Executive Vice President, Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2007
Affymax(R) Names Robert F. Venteicher, Ph.D., Vice President, Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2007
Affymax Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2007
Affymax(R) Announces Phase 3 Development Plan for Hematide(TM)
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2007
Affymax(R) Announces Resignation of Elizabeth A. Czerepak From its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2007
Affymax(R) Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide(TM) for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease
Biopharmacetuicals
 HSMN NewsFeed - 12 Apr 2007
Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide(TM) for the Treatment of Anemia in Dialysis Patients
Biopharmaceuticals
 HSMN NewsFeed - 25 Oct 2006
Affymax Appoints Grace U. Shin as Vice President of Legal Affairs and Corporate Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2006
Affymax Appoints Daniel K. Spiegelman to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jul 2006
Affymax Appoints Jeffrey H. Knapp as Chief Commercialization Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2006
Affymax Appoints Kay Slocum as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2006
Affymax and Takeda Announce Agreement to Develop and Commercialize Hematide(TM) in Japan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Jan 2006
Affymax Appoints Paul B. Cleveland as Chief Financial Officer and Executive Vice President of Corporate Development
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 8 additional stories matching:
Hematide
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.